Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Assets

$106.22M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Assets

Latest reported$106.22M
LCTX Quarterly Total Assets ($5.20M → $106.22M)
High-resolution chart · PNG

LCTX total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
106,220,000
109,533,000
112,584,000
89,639,000
90,799,000
111,753,000
113,218,000
96,594,000
102,802,000
108,483,000
101,019,000
106,153,000
111,688,000
113,205,000
123,664,000
131,148,000
135,922,000
144,520,000
174,545,000
131,212,000
134,754,000
127,928,000
107,949,000
103,090,000
112,080,000
118,882,000
125,478,000
132,978,000
151,691,000
183,715,000
101,660,000
176,077,000
112,251,000
110,395,000
173,241,000
221,867,000
193,353,000
205,216,000
142,572,000
147,574,000
104,327,000
80,114,000
94,660,000
76,859,000
79,610,000
69,703,470
74,900,906
55,654,664
65,985,440
57,949,895
57,729,750
30,853,664
39,893,767
35,297,393
29,748,593
32,870,336
38,381,408
38,977,899
45,829,695
50,875,731
53,457,744
56,890,231
53,272,659
41,292,526
34,146,912
12,700,853
13,433,071
9,266,214
5,783,642
1,696,104
1,035,457
1,025,835
609,474
561,728
175,102
62,032
200,650
366,650
650,507
842,642
1,140,586
1,762,327
1,958,784
568,967
729,307
832,850
1,521,589
1,635,736
2,160,405
2,281,340
1,071,545
1,300,208
806,932
1,420,242
1,496,081
1,963,087
730,165
1,267,445
1,941,375
2,383,737
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.